Ani Pharmaceutic (ANIP) Total Assets by Year
Ani Pharmaceutic closed fiscal year 2025 with $1.4B in total assets, $899.7M in total liabilities and $540.7M in shareholder equity. This represents an increase of 12.1% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Ani Pharmaceutic has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ANIP Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.4B+12.1% | $1.3B+42.0% | $904.4M+19.0% | $760.1M-1.5% | $771.6M+67.3% | $461.2M+1.0% | $456.8M+6.1% | $430.6M+4.5% | $412.1M+27.7% | $322.9M+13.2% | $285.3M+9.9% | $259.6M+483.3% | $44.5M+223.7% | $13.7M-78.0% | $62.4M |
| Total Liabilities | $899.7M+5.1% | $855.9M+91.6% | $446.8M+6.0% | $421.5M+2.1% | $412.9M+55.5% | $265.5M+8.8% | $244.0M+4.6% | $233.3M-1.7% | $237.4M+54.9% | $153.2M+22.4% | $125.2M+4.5% | $119.8M+3285.3% | $3.5M-93.7% | $56.5M-41.6% | $96.7M |
| Total Equity | $540.7M+33.9% | $403.7M-6.7% | $432.7M+38.0% | $313.7M-6.0% | $333.9M+70.6% | $195.7M-8.0% | $212.8M+7.9% | $197.3M+12.9% | $174.8M+3.0% | $169.6M+6.0% | $160.1M+14.5% | $139.8M+241.3% | $41.0M+195.9% | -$42.7M-24.6% | -$34.3M |
ANIP Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.5B+11.3% | $1.4B+10.0% | $1.4B+12.1% | $1.4B+9.4% | $1.3B+45.9% | $1.3B+41.3% | $1.3B+42.0% | $1.3B+44.7% | $920.8M+7.1% | $914.5M+19.5% | $904.4M+19.0% | $889.9M+20.4% |
| Total Liabilities | $896.9M+1.8% | $859.7M+1.3% | $899.7M+5.1% | $902.3M+5.3% | $881.4M+100.3% | $849.0M+94.0% | $855.9M+91.6% | $856.6M+96.8% | $440.1M+3.6% | $437.7M+2.8% | $446.8M+6.0% | $435.2M+8.1% |
| Total Equity | $597.2M+36.7% | $562.3M+34.3% | $540.7M+33.9% | $505.8M+24.6% | $436.8M-4.2% | $418.6M-7.4% | $403.7M-6.7% | $405.9M-5.6% | $455.8M+11.3% | $452.0M+43.6% | $432.7M+38.0% | $429.9M+37.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Ani Pharmaceutic financials
Frequently Asked Questions
What was Ani Pharmaceutic's total assets in fiscal year 2025?
Ani Pharmaceutic closed fiscal year 2025 with $1.4B in total assets, $899.7M in total liabilities and $540.7M in shareholder equity.
How fast is Ani Pharmaceutic's total assets growing?
Ani Pharmaceutic (ANIP) total assets rose by 12.1% year over year, from $1.3B to $1.4B in fiscal year 2025.
How has Ani Pharmaceutic's total assets changed over the years?
Across the 15 fiscal years this page covers, Ani Pharmaceutic (ANIP) total assets went from $62.4M in fiscal year 2011 to $1.4B in fiscal year 2025.
What was Ani Pharmaceutic's total assets in the most recent quarter?
Ani Pharmaceutic (ANIP) reported $1.5B in total assets in Q2 2026. This represents an increase of 11.3% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Ani Pharmaceutic (ANIP) reported on that line in every period on record.